Chemical Formula: C12H15NO5S

Chemical Formula C12H15NO5S

Found 18 metabolite its formula value is C12H15NO5S

Faropenem

(+)-(5R,6S)-6-((1R)-1-Hydroxyethyl)-7-oxo-3-((2R)-tetrahydro-2-furyl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid

C12H15NO5S (285.0671)


Faropenem is an orally active beta-lactam antibiotic belonging to the penem group. It is resistant to some forms of extended-spectrum beta-lactamase. It is available for oral use. Faropenem was developed by Daiichi Asubio Pharma, which markets it in two forms. The sodium salt faropenem sodium, available under the trade name Farom, has been marketed in Japan since 1997. (CID 636379 from PubChem) The prodrug form faropenem medoxomil (also known as faropenem daloxate) has been licensed from Daiichi Asubio Pharma by Replidyne, which plans to market it in conjunction with Forest Pharmaceuticals. The trade name proposed for the product was Orapem, but company officials recently announced this name was rejected by the FDA.

   

2-(BENZOYLAMINO)-4-(METHYLSULFONYL)BUTANOIC ACID

2-(BENZOYLAMINO)-4-(METHYLSULFONYL)BUTANOIC ACID

C12H15NO5S (285.0671)


   

4-HYDROXY-1-[(4-METHYLPHENYL)SULFONYL]-2-PYRROLIDINECARBOXYLIC ACID

4-HYDROXY-1-[(4-METHYLPHENYL)SULFONYL]-2-PYRROLIDINECARBOXYLIC ACID

C12H15NO5S (285.0671)


   

1-(4-methoxyphenyl)sulfonylpyrrolidine-2-carboxylic acid

1-(4-methoxyphenyl)sulfonylpyrrolidine-2-carboxylic acid

C12H15NO5S (285.0671)


   

(2R,4S)-4-hydroxy-1-(4-methylphenyl)sulfonyl-pyrrolidine-2-carboxylate

(2R,4S)-4-hydroxy-1-(4-methylphenyl)sulfonyl-pyrrolidine-2-carboxylate

C12H15NO5S (285.0671)


   

4-(Methylsulfonyl)-3-morpholinobenzoic Acid

4-(Methylsulfonyl)-3-morpholinobenzoic Acid

C12H15NO5S (285.0671)


   

ethyl 2-(4-acetamidophenyl)sulfonylacetate

ethyl 2-(4-acetamidophenyl)sulfonylacetate

C12H15NO5S (285.0671)


   

4-(Methylsulfonyl)-2-morpholinobenzoic Acid

4-(Methylsulfonyl)-2-morpholinobenzoic Acid

C12H15NO5S (285.0671)


   

4-METHYL-3-(MORPHOLINE-4-SULFONYL)BENZOICACID

4-METHYL-3-(MORPHOLINE-4-SULFONYL)BENZOICACID

C12H15NO5S (285.0671)


   

METHYL 2-(MORPHOLINOSULFONYL)BENZOATE

METHYL 2-(MORPHOLINOSULFONYL)BENZOATE

C12H15NO5S (285.0671)


   

4-[(TETRAHYDRO-FURAN-2-YLMETHYL)-SULFAMOYL]-BENZOIC ACID

4-[(TETRAHYDRO-FURAN-2-YLMETHYL)-SULFAMOYL]-BENZOIC ACID

C12H15NO5S (285.0671)


   

6beta-[(S)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid

6beta-[(S)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid

C12H15NO5S (285.0671)


   

(5R)-6-(1-hydroxyethyl)-7-oxo-3-[(2R)-tetrahydrofuran-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

(5R)-6-(1-hydroxyethyl)-7-oxo-3-[(2R)-tetrahydrofuran-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C12H15NO5S (285.0671)


   

(5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-(oxolan-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

(5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-(oxolan-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C12H15NO5S (285.0671)


   

(5R,6S)-6-[(1S)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

(5R,6S)-6-[(1S)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C12H15NO5S (285.0671)


   

6alpha-[(R)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid

6alpha-[(R)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid

C12H15NO5S (285.0671)


   
   

2-(4-Hydroxy-3,5-dimethoxyphenyl)-1,3-thiazolidine-4-carboxylic acid

2-(4-hydroxy-3,5-dimethoxyphenyl)-1,3-thiazolidine-4-carboxylic acid

C12H15NO5S (285.0671)